
Silsense Technologies S.A.
Manufacture of irradiation, electromedical and electrotherapeutic equipment
Overview
Silsense Technologies is engaged in the IT industry, focusing on the development of innovative technologies based on Polish scientific research. The company has created a scalable telemedicine solution that connects medical specialists with patients and their families, utilizing certified medical devices for monitoring vital parameters. Additionally, Silsense collaborates with academic institutions and research centers to enhance the effectiveness of its projects.
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 5 of 6 financial statements were filed late (the longest delay 321 days for 2021). All were audited by a statutory auditor.
- 2025not filed
- 202429/01/2026
- 202307/01/2025
- 202229/04/2024
- 202101/06/2023
- 202030/11/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.
Results vs industry
Industry
Authorized Representatives
Manner of representation
Two members of the management board acting jointly.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2013-06-26.
64 1050 1298 1000 0091 3515 3048
59 1050 1298 1000 0024 4179 3268
65 1050 1298 1000 0091 3515 3030
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jan 23, 2024 | Dissolution without liquidation opened |
Public aid
4 public aid cases recorded, with a total value of $801,390.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 22, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $122$122 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 16, 2021 | Aid for research and development projects: industrial research | $417K$416,958 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Jun 16, 2021 | Aid for research and development projects: experimental development | $377.4K$377,435 | Dyrektor Narodowego Centrum Badań i Rozwoju |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Infotower Business Solutions sp. z o.o. | $1,903,379.58 | infotower.pl | ||
| Technika It sp. z o.o. | $765,379.49 | technikait.com | ||
| Ives-System sp. z o.o. | $709,549.49 | ives-system.com | ||
| Biobyte sp. z o.o. | $698,902.05 | biobyte.pl | ||
| ITGO sp. z o.o. | $524,815.10 | itgo.com.pl | ||
| Digitmed S.A. | $382,907.91 | digitmed.pl | ||
| Thaumatec Iot Cloud Services sp. z o.o. | $261,636.43 | thaumatec.com | ||
| Codehome sp. z o.o. | $234,261.00 | codehome.eu | ||
| Technicenter sp. z o.o. | $151,583.46 | technicenter.eu | ||
| Infotower Technologies sp. z o.o. | $90,348.84 | technologies.infotower.pl |
FAQ
Last updated: 2026-03-26
